Injection for leading cause of severe vision loss and legal blindness.
Health System News
First new treatment of its kind in over 20 years.
Characterized by severe abdominal pain.
Only 50% of COPD patients are estimated to be vaccinated.
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
Biosimilars may need more time to devleop in the market.
For granulomatosis with microscopic polyangiitis in children.
Now approved for risk reductions in patients with type 2 diabetes mellitus.
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
Biologic medicines could lower spending by $153 billion by 2023.